Related Experiment Video
Updated: Apr 29, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site
Kejia Ding1, Annie Wang1, Mark A Boerneke1
1Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.
Abstract:
We describe the exploration of N1-aryl-substituted benzimidazoles as ligands for the hepatitis C virus (HCV) internal ribosome entry site (IRES) RNA. The design of the compounds was guided by the co-crystal structure of a benzimidazole viral translation inhibitor in complex with the RNA target. Structure-binding activity relationships of aryl-substituted benzimidazole ligands were established that were consistent with the crystal structure of the translation inhibitor complex.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Subviral Agents
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors of Bacterial Protein Synthesis
Anthelminthic Agents

